U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07587710) titled 'A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in People With Reduced Liver Function and Normal Liver Function' on May 08.
Brief Summary: The study is testing a new study medicine to treat people with overweight/obesity and type 2 diabetes. The aim of this study is to see if it is safe and to find out how it works in people with reduced liver function and people with normal liver function.
Study Start Date: May 13
Study Type: INTERVENTIONAL
Condition:
Overweight
Obesity
Intervention:
DRUG: NNC0487-0111
NNC0487-0111 will be administered subcutaneously using PDS29...